Haemonetics (NYSE: HAE) — Perfil da empresa, notícias e dados financeiros
Haemonetics manufactures blood and plasma supplies to enhance safety and efficiency in blood management across healthcare settings.
Haemonetics
Haemonetics (NYSE:HAE) specializes in the development and manufacturing of blood and plasma supplies and equipment. This focus encompasses a broad range of products and services designed to support blood processing, storage, and transfusion across various healthcare settings. Haemonetics aims to innovate within the blood management industry, striving to improve safety and efficiency in blood and plasma collection, processing, and analysis. Their projects and objectives revolve around enhancing patient care and supporting healthcare providers with advanced solutions for blood management, underscoring their commitment to saving lives and improving patient outcomes.
Resumo
Operações
Produtos e/ou serviços de Haemonetics
- Plasma Collection Systems and Software - Advanced equipment and software solutions designed to optimize the efficiency and safety of collecting plasma.
- Blood Center Technologies - Comprehensive portfolio of devices, disposables, and software for blood and component collection.
- Hospital Products - A range of devices and systems to manage blood and bleeding in surgical and emergency settings.
- Cell Saver Systems - Leading technology for autologous blood recovery during surgical procedures, reducing the need for transfusions.
- TEG Hemostasis Analyzer Systems - Diagnostic instruments and consumables that help assess and manage hemostasis in surgery and critical care.
- NexSys PCS Device - Next-generation plasma collection system designed to enhance donor comfort and increase collection efficiency.
equipe executiva do Haemonetics
- Christopher A. SimonCEO, President & Director
- James C. D'AreccaCFO, Executive VP & Financial Officer
- Frank W. ChanExecutive VP & COO
- Michelle L. BasilExecutive VP, General Counsel & Secretary
- Roy GalvinExecutive VP & Chief Commercial Officer
- Farris Maryanne E. MaunsellVP, Chief Accounting Officer & Principal Accounting Officer
- Olga GuyetteVP of IR & Treasury
- Josh GitelsonSenior Director of Global Communications
- Rajeev VarmaSenior Vice President of Strategy & Corporate Development
- Laurie A. MillerSenior VP & Chief Human Resources Officer
Últimas notícias sobre a Haemonetics
Principais indicadores financeiros
Resultados divulgados pela Haemonetics , em USD.
- Cap. de mercado
- 5,5 bi
- Receita (TTM)
- 1,4 bi
- P/L
- 58.0
- LPA (diluído, TTM)
- 2.1
- Dividend yield
- —
- Margem de lucro
- 7.1%
| Fim do ano fiscal | Receita | Resultado operacional | Lucro líquido |
|---|---|---|---|
| 1,3 bi | 241,4 mi | 97,3 mi | |
| 1,4 bi | 221,8 mi | 167,7 mi | |
| 1,3 bi | 164,9 mi | 117,6 mi | |
| 1,2 bi | 156 mi | 115,4 mi |